Table 10.
PP | ||||||
---|---|---|---|---|---|---|
| ||||||
Coefficient | 95% lower | 95% upper | p | p | ||
Intercept | −0.241 | −1.511 | 1.029 | 0.710 | - | |
Days | 7 | Reference | - | |||
14 | 0.271 | −0.420 | 1.034 | 0.486 | ||
PPI | ES-OM | Reference | 0.375 | |||
LAC | 0.076 | −0.995 | 1.146 | 0.890 | ||
OAC | 0.155 | −1.230 | 1.539 | 0.827 | ||
PAC | 0.559 | −0.550 | 1.668 | 0.324 |
As age and gender information were generally given in all studies for patients participating in the study and because ITT covered all randomized patients, the PP analysis could not be used in the data analysis.
The treatment application time for ITT (p=0.169), age (p=0.898), gender ratio (p=0.588), and application of different PPIs (p=0.376) did not affect the success of the treatment.
The treatment application time for PP (p=0.486) and the application of different PPIs (p=0.375) did not affect the success of the treatment.